Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02866669 · ClinicalTrials.gov registry record · NA

Southeastern Collaboration to Improve Blood Pressure Control

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
1,592
Enrollment target

NCT02866669: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT02866669 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1,592 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02866669, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
1,592 participants
Enrollment target

Study Summary

The central objective of this proposal is to rigorously compare two strategies designed to improve BP control in primary care practices serving rural Southeastern African Americans with low socioeconomic status (SES) living in the "Black Belt". In year 1, we're engaging community members (community members who have experience being community peer advisors or have high blood pressure) to develop the study interventions and protocols. In years 2-5, the investigators will test the interventions. Year 2-5, Aim 3: Enroll 80 practices and 25 African American patients with uncontrolled HTN at each practice (total n=2000) in a cluster-randomized, controlled, 4-arm pragmatic implementation trial to evaluate the three multi- component, multi-level functional interventions finalized in the UH2 phase compared with enhanced usual care. The study's 4 arms are: 1. Enhanced Usual Care: Practices are provided with educational materials and tools to enhance patient care 2. Peer Coaching: Patients enrolled in these practices will be matched with a peer coach. The peer coach helps the patient to set goals around self-management, including medications, home monitoring, and diet and exercise, and she helps the patient to strategize how to accomplish the goals, using motivational interviewing techniques 3. Practice Facilitation: Practices randomized to this arm will work with a practice facilitator. Practice facilitation is a highly customized, staged approach to helping a practice to implement process and structural changes to enhance the quality of care and improve patient and staff satisfaction 4. Peer coaching and practice facilitation: Practices randomized to this arm will receive both the peer coach intervention and the practice facilitation intervention. Practice facilitators and peer coaches will receive the same training for this hybrid intervention, but the practice facilitator change packet will add examples of activities that integrate peer coaches.

Primary Outcome

Blood pressure (BP) control is defined as systolic pressure less than 140 mm Hg and diastolic pressure less than 90 mm Hg. Difference in BP control at 12 month follow-up between trial arms. BP was assessed in the practice by a research assistant using a standardized protocol at baseline, 6, and 12 months.

Interventions

  • BEHAVIORAL Enhanced usual care
  • BEHAVIORAL Peer Coach
  • BEHAVIORAL Practice Facilitation

Trial Details

FieldValue
Enrollment Target 1,592 participants
Start Date 2017-05-03
Est. Completion 2021-02-28
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT02866669 record still lists

NCT02866669 is an interventional study that assigns participants to a tested intervention. Its 1,592 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% higher).

The record links to 0 conditions, and to 3 interventions - of which Enhanced usual care is the first listed.

NCT02866669 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02866669 about?

NCT02866669 is a clinical study titled "Southeastern Collaboration to Improve Blood Pressure Control". The central objective of this proposal is to rigorously compare two strategies designed to improve BP control in primary care practices serving rural Southeastern African Americans with low socioeconomic status (SES) living in the "Black Belt". In year 1, we're engaging community members (community...

What is the current status of trial NCT02866669?

This trial is currently completed. It is a NA study. The enrollment target is 1,592 participants. The study started on 2017-05-03. Estimated completion is 2021-02-28.

What interventions are being tested in trial NCT02866669?

The interventions under investigation include: Enhanced usual care (BEHAVIORAL), Peer Coach (BEHAVIORAL), Practice Facilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT02866669?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02866669's enrollment target sits among peer trials

1,592 64th of 2000 higher than 1,937 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05243797 · 1,594 participants · Phase 3

    Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

  • NCT05552222 · 1,590 participants · Phase 3

    A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

  • NCT06632457 · 1,590 participants · Phase 3

    LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  • NCT00646022 · 1,600 participants

    Natural History of Familial Carcinoid Tumor

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02866669, the US trial registry maintained by the National Library of Medicine. NCT02866669 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.